JavaScript Menu, DHTML Menu Powered By Milonic
 
 

CTN 239 Principal Investigator Dr. Jean-Pierre Routy (right) and Dr. Renu Jain (Argos Therapeutics) at AIDS 2008 in Mexico City.
Customized immunotherapy designed to fit

Coined as the "haute couture" of HIV therapy, an experimental immune-based vaccine is redefining the notion of personalized treatment.
Read more in Connections
Fall 2008 [PDF] 203 KB





2007-2008 CTN Postdoctoral Fellows: Drs. Gonzalo Alvarez and Darrell Tan		 CTN fellowships call for applicants
Awards valued up to $55,000 are available through the CTN Postdoctoral Fellowship Awards Programme for the 2009-2010 cycle. The deadline for submissions is January 31, 2009.


Find out more
Clinical Trials
Latest Enrolling Trial: CTN 236
HPV vaccine in HIV positive girls and women

Find out more
Search for enrolling and ongoing trials


CTN Online Directory (July 2008)
Download
Password Protected [PDF] 139 KB
CAHR 2009 Abstract Deadline
Jan. 18, 2009
More info
Featured trial
CTN 239: Phase II study of AGS-004 an immunotherapeutic agent in combination with ART followed by ART interruption
Read about this trial
PubMed
A service of the U.S. National Library of Medicine
CAPT Network
Canada-Africa Prevention Trials Network
CAHR
Canadian Association for HIV Research
Health Canada
Federal Initiative to Address HIV/AIDS in Canada
Canadian AIDS
Treatment Information Exchange
© Canadian HIV Trials Network 2005 | Accessibility | Disclaimer